UPDATE : Saturday, October 12, 2019
상단여백
Lenvima to get benefit as 1st-line treatment of hepatocellular carcinoma
Lenvima (ingredient: lenvatinib), a new liver cancer drug that arrived in a...
by Kim Yun-mi  |  2019-09-16 16:20
라인
'Roche Korea to put patient accessibility first'
Roche Korea, the number one company in the domestic anticancer market, is l...
by Lee Han-soo  |  2019-09-16 15:41
라인
Regulator inspects heartburn drugs after US finds carcinogen
After U.S. health officials said they detected low levels of a potentially ...
by Lee Hye-seon  |  2019-09-16 14:01
라인
GC’s Hunter syndrome drug to get priority screening in China
GC said that China’s National Medical Products Administration (NMPA) has de...
by Lee Han-soo  |  2019-09-16 13:56
라인
FDA warns against pneumonitis with CDK 4/6 inhibitor drugs for breast cancer
The U.S. Food and Drug Administration added a warning that the entire class...
by Kim Yun-mi  |  2019-09-16 11:39
라인
Number of antibiotic-resistant infections increase faster than 2018
The number of patients infected with Carbapenem-resistant Enterobacteriacea...
by Lee Han-soo  |  2019-09-12 07:23
라인
GSK’s chronic hand eczema treatment faces local competition
GSK Korea is facing competition from DongKoo Bio&Pharma for its exclusive c...
by Lee Han-soo  |  2019-09-12 07:22
라인
KCDC pegs salted clam as culprit behind hepatitis A rise
The Korea Centers for Disease Control and Prevention (KCDC) said that it ha...
by Lee Han-soo  |  2019-09-12 07:22
라인
Korea sees a spike in depression, bipolar disorder
The number of depression and bipolar disorder patients is steadily increasi...
by Lee Han-soo  |  2019-09-11 15:16
라인
Chong Kun Dang wins patent suit against Novartis over immunosuppressant
Chong Kun Dang said it has won the lawsuit against Novartis over the patent...
by Jeong Sae-im  |  2019-09-11 15:16
라인
AstraZeneca to challenge Roche in small-cell lung cancer treatment market
AstraZeneca’s Imfinzi (ingredient: durvalumab) has sharpened up its weapon ...
by Kim Yun-mi  |  2019-09-11 14:18
라인
Amgen fetes 1st anniversary of getting expanded indication for Repatha
Amgen Korea said that its cardio-vascular disease business unit has held an...
by Lee Han-soo  |  2019-09-11 13:56
라인
Hanmi to launch 3-substance combination in Latin America
Hanmi Pharmaceutical said that it has become the first local corporation to...
by Lee Han-soo  |  2019-09-11 13:56
라인
Daewoong to test botulinum toxin Nabota for hair loss
Daewoong Pharmaceutical said it would conduct a clinical trial on botulinum...
by Jeong Sae-im  |  2019-09-11 13:56
라인
[Column] Digital healthcare for efficient distribution of medical resources
The Ministry of Health and Welfare recently announced a short-term measure ...
by Song Seung-jae  |  2019-09-10 15:46
라인
Novartis withdraws suit against Ahngook’s generic drug
Novartis canceled its lawsuit against Ahngook Pharmaceutical’s anti-diabeti...
by Jeong Sae-im  |  2019-09-10 15:38
라인
AI that can diagnose ADHD developed
Seoul National University Hospital researchers have developed an artificial...
by Lee Han-soo  |  2019-09-10 15:36
라인
Top court rejects financial regulator’s retry to discipline Samsung BioLogics
The Financial Services Commission (FSC)'s disciplinary action against S...
by Jeong Sae-im  |  2019-09-10 14:36
라인
Immunotherapies Opdivo, Keytruda score high in real setting
Immunotherapies Opdivo Inj. and Keytruda Inj. showed excellent efficacy and...
by Kim Eun-young  |  2019-09-10 12:49
라인
Canada OKs Celltrion's biosimilar
Celltrion said that Health Canada has given the go-ahead for Herzuma (Ingre...
by Lee Han-soo  |  2019-09-10 12:48
여백
여백
여백
Back to Top